The assessment of severity is crucial in the management of the disease. Current methods of risk stratification in AP have a limited value, as they provide little additional information thus may delay appropriate management. Early recognition of severe disease may prevent serious adverse events and improve patient management as well as overall clinical outcome.
The selected parameters that show the strongest correlation with severe disease course will be further utilized as potential early severity prognostic markers for prospective new patient stratification. Comparison of patients’ clinical course with the obtained results of early risk stratification may validate the utilized parameters as prognostic markers.
Authorship policy: 30 patients - 1 co-author
Etichal approval number: ETT TUKEB ad.30595/2014
Trial registration number: ISRCTN10525246
Pre-study article: J. Gastrointestin Liver Dis